Mystery disease is affecting more and more young people in the Canadian province

Fredericton – Memory loss, muscle wasting and hallucinations. These are just some of the goal setting shareware that you can use in New Brunswick, Canada. Experts are confused, it may be an unknown neurological disease.

For about two years, doctors in Canada have been asking themselves a big question. More and more young people are experiencing common symptoms that can be a new disease that affects them neurologically. They lose weight indescribably, cramps, balance problems and blurred vision. In the province of New Brunswick 48 patients have been identified, but that may be three times higher. This is because more and more patients are waiting for their clinical evaluation.

An employee of the Vitalite Health Network, one of the province’s two health officials, told the Guardian that the disease did not just affect New Brunswick residents. There are at least nine cases in which two individuals without close contact and genetic relationships have developed symptoms. So environmental factors may be involved. For example, a woman who has been caring for her husband since he began to show signs of dementia and ataxia, suddenly fell asleep, began to have hallucinations, dementia, and muscle weakness.

What is known about these patients is that they have no previous disease or genetic predisposition before giving symptoms. But the debate is provoking, with many experts and the state of New Brunswick questioning the diagnosis and believing that those who actually touch it are not a mysterious disease, but a disease or known disease. On the Internet, the province writes, “The clinical signs and symptoms are related to Creutzfeldt-Jakob’s disease, but with different characteristics. To date, all test results have been negative for known forms of human bryon disease.

Global News told the story of Gabriel Gormier who noticed the first signs of the disease in 2019. Today he is 20 years old and has memory, movement and vision impairments. The life expectancy of patients with this disease is 18 to 36 months from the onset of symptoms. As of 2019, nine people have died from the disease. Knowing that the moment is near, the young woman and her family, despite the constant struggles, try to keep the memories, give and take as much as possible.

The family of a patient who died of a severe course of this mysterious disease demanded that the body of the deceased be tested for neurotoxins. Of these, beta-methylamino-L-alanine (BMAA) has also been reported to have the highest concentrations in liver. This particular crustacean is an integral part of the economy of the coastal communities of New Brunswick.

One scientist said that everything was ready for this long and complicated experiment, but “New Brunswick in particular told us not to move forward.” The province, which has already denied in recent months that the onset of symptoms is related to dietary or environmental factors, is preparing to announce in the coming weeks that the panel of diagnosed cases is only the result of a misdiagnosis.